Exact Mass: 432.1198

Exact Mass Matches: 432.1198

Found 102 metabolites which its exact mass value is equals to given mass value 432.1198, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Licoagroside B

3-hydroxy-3-methyl-5-oxo-5-({3,4,5-trihydroxy-6-[(2-methyl-4-oxo-4H-pyran-3-yl)oxy]oxan-2-yl}methoxy)pentanoic acid

C18H24O12 (432.1268)


Licoagroside B is found in herbs and spices. Licoagroside B is isolated from hairy root cultures of Glycyrrhiza glabra (licorice). Isolated from hairy root cultures of Glycyrrhiza glabra (licorice). Licoagroside B is found in tea and herbs and spices.

   

Apiosylglucosyl 4-hydroxybenzoate

6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl 4-hydroxybenzoic acid

C18H24O12 (432.1268)


Apiosylglucosyl 4-hydroxybenzoate is found in herbs and spices. Apiosylglucosyl 4-hydroxybenzoate occurs in sage.

   

1-(Perfluorohexyl)octane

1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane

C14H17F13 (432.1123)


   

Asperulosidic acid

7-(Acetyloxymethyl)-5-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

5-(1,1-Dihydroxythiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-8-hydroxy-1,6-naphthyridine-7-carboxamide

5-(1,1-dihydroxy-1lambda4,2-thiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-8-hydroxy-1,6-naphthyridine-7-carboxamide

C20H21FN4O4S (432.1267)


   

Ulixertinib

4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide

C21H22Cl2N4O2 (432.112)


   

ACon1_001484

(1S,4aS,5S,7aS)-7-(acetoxymethyl)-5-hydroxy-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-1,4a,5,7a-tetrahydrocyclopenta[d]pyran-4-carboxylic acid

C18H24O12 (432.1268)


Asperulosidic acid is a glycoside and an iridoid monoterpenoid. Asperulosidic acid is a natural product found in Spermacoce alata, Knoxia roxburghii, and other organisms with data available. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2].

   

Asperulosidic

(1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


Asperulosidic acid is a glycoside and an iridoid monoterpenoid. Asperulosidic acid is a natural product found in Spermacoce alata, Knoxia roxburghii, and other organisms with data available. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2].

   

Asperulosidic acid

Asperulosidic acid

C18H24O12 (432.1268)


Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2].

   

Trichodermamide A

Trichodermamide A

C20H20N2O9 (432.1169)


CONFIDENCE Penicillium corvianum

   

6-O-Acetylscandoside

6-O-Acetylscandoside

C18H24O12 (432.1268)


   

Griselinoside

Griselinoside

C18H24O12 (432.1268)


   

Calomelanol G

3,4,7,8-Tetrahydro-5-hydroxy-4-(4-hydroxyphenyl)-8-(4-methoxyphenyl)-2H,6H-benzo[1,2-b:5,4-b]dipyran-2,6-dione

C25H20O7 (432.1209)


   

Linderofruticoside B

Linderofruticoside B

C18H24O12 (432.1268)


   
   
   

Maybridge1_006057

Maybridge1_006057

C24H21ClN4S (432.1175)


   

beta-(5,7,4-trihydroxy-flavon-8-yl)-beta-phenylpropionic acid methyl ester

beta-(5,7,4-trihydroxy-flavon-8-yl)-beta-phenylpropionic acid methyl ester

C25H20O7 (432.1209)


   

10-O-acetylmonotropein

10-O-acetylmonotropein

C18H24O12 (432.1268)


   

3-hydroxy-4-[O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranosyloxy]benzaldehyde|bretschneideroside B

3-hydroxy-4-[O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranosyloxy]benzaldehyde|bretschneideroside B

C18H24O12 (432.1268)


   

(7R)-8-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]galangin

(7R)-8-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]galangin

C25H20O7 (432.1209)


   

Myo-inositol, hexaacetate

Myo-inositol, hexaacetate

C18H24O12 (432.1268)


   

Me ester-5, 7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-beta-phenyl-4H-1-benzopyran-8-propanoic acid

Me ester-5, 7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-beta-phenyl-4H-1-benzopyran-8-propanoic acid

C25H20O7 (432.1209)


   
   

Asperuloside acid

Asperulosidic acid

C18H24O12 (432.1268)


Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2]. Asperulosidic Acid (ASPA), a bioactive iridoid glycoside, is extracted from the herbs of Hedyotis diffusa Willd. Asperulosidic Acid (ASPA) has anti-tumor, anti-oxidant, and anti-inflammatory activities[1]. ASPA is related to the inhibition of inflammatory cytokines (TNF-α, IL-6) and mediators via suppression of the NF-κB and mitogen-activated protein kinase (MAPK) signaling pathways[2].

   

C18H24O12_2-Methyl-4-oxo-4H-pyran-3-yl 6-O-(4-carboxy-3-hydroxy-3-methylbutanoyl)-beta-D-glucopyranoside

NCGC00384576-01_C18H24O12_2-Methyl-4-oxo-4H-pyran-3-yl 6-O-(4-carboxy-3-hydroxy-3-methylbutanoyl)-beta-D-glucopyranoside

C18H24O12 (432.1268)


   

C18H24O12_Cyclopenta[c]pyran-4-carboxylic acid, 7-[(acetyloxy)methyl]-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-, (1S,4aS,5S,7aS)

NCGC00180458-02_C18H24O12_Cyclopenta[c]pyran-4-carboxylic acid, 7-[(acetyloxy)methyl]-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-, (1S,4aS,5S,7aS)-

C18H24O12 (432.1268)


   

(1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid

(1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

3-hydroxy-3-methyl-5-oxo-5-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-methyl-4-oxopyran-3-yl)oxyoxan-2-yl]methoxy]pentanoic acid

3-hydroxy-3-methyl-5-oxo-5-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-methyl-4-oxopyran-3-yl)oxyoxan-2-yl]methoxy]pentanoic acid

C18H24O12 (432.1268)


   

Licoagroside B (Not validated)

Licoagroside B (Not validated)

C18H24O12 (432.1268)


Annotation level-3

   

(1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid_major

(1S,4aS,5S,7aS)-7-(acetyloxymethyl)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid_major

C18H24O12 (432.1268)


   

Ala Cys Cys His

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H24N6O5S2 (432.125)


   

Ala Cys His Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C15H24N6O5S2 (432.125)


   

Ala His Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H24N6O5S2 (432.125)


   

Cys Ala Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H24N6O5S2 (432.125)


   

Cys Ala His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C15H24N6O5S2 (432.125)


   

Cys Cys Ala His

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H24N6O5S2 (432.125)


   

Cys Cys His Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C15H24N6O5S2 (432.125)


   

Cys His Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-sulfanylpropanoic acid

C15H24N6O5S2 (432.125)


   

Cys His Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]propanoic acid

C15H24N6O5S2 (432.125)


   

His Ala Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H24N6O5S2 (432.125)


   

His Cys Ala Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanoic acid

C15H24N6O5S2 (432.125)


   

His Cys Cys Ala

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanoic acid

C15H24N6O5S2 (432.125)


   

TyrMe-Asp-OH

(S)-2-(3-((4-methoxybenzyl)oxy)-4-nitrobenzamido)pentanedioic acid

C20H20N2O9 (432.1169)


   

Apiosylglucosyl 4-hydroxybenzoate

6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl 4-hydroxybenzoate

C18H24O12 (432.1268)


   

Licoagroside B

3-hydroxy-3-methyl-5-oxo-5-({3,4,5-trihydroxy-6-[(2-methyl-4-oxo-4H-pyran-3-yl)oxy]oxan-2-yl}methoxy)pentanoic acid

C18H24O12 (432.1268)


A monosaccharide derivative resulting from the formal condensation of the hydroxy group of 2-methyl-4-oxo-4H-pyran-3-yl beta-D-glucopyranoside with the carboxy group of 3-hydroxy-3-methylglutaric acid.

   

1-ethyl-2-[3-(1-ethylquinolin-1-ium-2-yl)prop-2-enylidene]quinoline,bromide

1-ethyl-2-[3-(1-ethylquinolin-1-ium-2-yl)prop-2-enylidene]quinoline,bromide

C25H25BrN2 (432.1201)


   

GSK429286A

N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide

C21H16F4N4O2 (432.1209)


   

bis(4-(4-aminophenoxy)phenyl)sulfone

bis(4-(4-aminophenoxy)phenyl)sulfone

C24H20N2O4S (432.1144)


   

Torin 2

Torin 2

C24H15F3N4O (432.1198)


Torin 2 is an mTOR inhibitor with EC50 of 0.25 nM for inhibiting cellular mTOR activity, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM). Torin 2 also inhibits DNA-PK with an IC50 of 0.5 nM in the cell free assay. Torin 2 can suppress both mTORC1 and mTORC2. Torin 2 is an mTOR inhibitor with EC50 of 0.25 nM for inhibiting cellular mTOR activity, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM). Torin 2 also inhibits DNA-PK with an IC50 of 0.5 nM in the cell free assay. Torin 2 can suppress both mTORC1 and mTORC2.

   

Ulixertinib

Ulixertinib (BVD-523)

C21H22Cl2N4O2 (432.112)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line[1][2].

   

1,1-diethyl-4,4-quinocyanine bromide

1,1-diethyl-4,4-quinocyanine bromide

C25H25BrN2 (432.1201)


   

Ethyl 1-thio-beta-D-galactopyranoside 2,3-dibenzoate

Ethyl 1-thio-beta-D-galactopyranoside 2,3-dibenzoate

C22H24O7S (432.1243)


   

3,3-[Sulfonylbis(4,1-phenyleneoxy)]dianiline

3,3-[Sulfonylbis(4,1-phenyleneoxy)]dianiline

C24H20N2O4S (432.1144)


   

Guanosine 5-(morpholinophosphonic acid)

Guanosine 5-(morpholinophosphonic acid)

C14H21N6O8P (432.1158)


   

4-(4-Methoxyphenyl)-3-(4-methylphenyl)-5-[(4-nitrophenyl)methylthio]-1,2,4-triazole

4-(4-Methoxyphenyl)-3-(4-methylphenyl)-5-[(4-nitrophenyl)methylthio]-1,2,4-triazole

C23H20N4O3S (432.1256)


   

N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide

N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide

C23H20N4O3S (432.1256)


   

N-[(E)-[3-(4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylideneamino]benzenesulfonamide

N-[(E)-[3-(4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylideneamino]benzenesulfonamide

C23H20N4O3S (432.1256)


   

4-[[1-(2-Furanylmethyl)-2,4,6-trioxo-3-propan-2-yl-1,3-diazinan-5-ylidene]methylamino]benzenesulfonamide

4-[[1-(2-Furanylmethyl)-2,4,6-trioxo-3-propan-2-yl-1,3-diazinan-5-ylidene]methylamino]benzenesulfonamide

C19H20N4O6S (432.1104)


   

2-[(3S,6aR,8R,10aR)-1-(2-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

2-[(3S,6aR,8R,10aR)-1-(2-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C18H25ClN2O6S (432.1122)


   

[2-ethoxy-4-[(Z)-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methyl]phenyl] thiophene-2-carboxylate

[2-ethoxy-4-[(Z)-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methyl]phenyl] thiophene-2-carboxylate

C24H20N2O4S (432.1144)


   

FABP-IN-2

FABP-IN-2

C25H21ClN2O3 (432.1241)


FABP-IN-2 is a novel FABP3 ligand. FABP-IN-2 inhibits FABP3/FABP4 with an IC50 of 1.16 μM and 4.27 μM respectively[1].

   

Plazinemdor

Plazinemdor

C21H19ClF2N4O2 (432.1165)


Plazinemdor is a N-methyl-D-aspartate(NMDA) receptor positive allosteric modulator. Plazinemdor can be uses in the research of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system[1]..

   

(3r)-3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

(3r)-3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

C18H24O12 (432.1268)


   

(3s)-3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

(3s)-3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

C18H24O12 (432.1268)


   

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

(4as,5r,8r,8as)-n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

(4as,5r,8r,8as)-n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

C20H20N2O9 (432.1169)


   

(7s,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-(4-methoxyphenyl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1(10),2,8-triene-5,11-dione

(7s,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-(4-methoxyphenyl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1(10),2,8-triene-5,11-dione

C25H20O7 (432.1209)


   

10-o-acetylmonotropein

NA

C18H24O12 (432.1268)


{"Ingredient_id": "HBIN000179","Ingredient_name": "10-o-acetylmonotropein","Alias": "NA","Ingredient_formula": "C18H24O12","Ingredient_Smile": "CC(=O)OCC1(C=CC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "470","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

6-o-acetylscandoside

NA

C18H24O12 (432.1268)


{"Ingredient_id": "HBIN012611","Ingredient_name": "6-o-acetylscandoside","Alias": "NA","Ingredient_formula": "C18H24O12","Ingredient_Smile": "CC(=O)OC1C=C(C2C1C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)O)CO","Ingredient_weight": "432.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "507","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "138108972","DrugBank_id": "NA"}

   

6-o-epiacetylscandoside

NA

C18H24O12 (432.1268)


{"Ingredient_id": "HBIN012674","Ingredient_name": "6-o-epiacetylscandoside","Alias": "NA","Ingredient_formula": "C18H24O12","Ingredient_Smile": "CC(=O)OC1C=C(C2C1C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)O)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6868","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4,7-dimethyl 5-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl 5-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)


   

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

(1s,4as,5r,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5r,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

7-[(acetyloxy)methyl]-5-hydroxy-1-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

7-[(acetyloxy)methyl]-5-hydroxy-1-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

4,7-dimethyl (1r,4ar,7r,7ar)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl (1r,4ar,7r,7ar)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)


   

4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxybenzaldehyde

4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxybenzaldehyde

C18H24O12 (432.1268)


   

(1s,4as,5s,7as)-5-(acetyloxy)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5s,7as)-5-(acetyloxy)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

(3r)-3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

(3r)-3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

C18H24O12 (432.1268)


   

(1s,4as,7r,7as)-7-[(acetyloxy)methyl]-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,7r,7as)-7-[(acetyloxy)methyl]-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

methyl 5-{[(2r,3r,4r,5r)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-2-hydroxybenzoate

methyl 5-{[(2r,3r,4r,5r)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-2-hydroxybenzoate

C18H24O12 (432.1268)


   

4,7-dimethyl (1s,4as,7s,7as)-5-oxo-1-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl (1s,4as,7s,7as)-5-oxo-1-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)


   

(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl 4-hydroxybenzoate

(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl 4-hydroxybenzoate

C18H24O12 (432.1268)


   

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5s,7as)-7-[(acetyloxy)methyl]-5-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

5-(acetyloxy)-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

5-(acetyloxy)-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

7-[(acetyloxy)methyl]-7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylic acid

7-[(acetyloxy)methyl]-7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

4,4a-dimethyl (1s,4ar,7ar)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,6h,7h,7ah-cyclopenta[c]pyran-4,4a-dicarboxylate

4,4a-dimethyl (1s,4ar,7ar)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,6h,7h,7ah-cyclopenta[c]pyran-4,4a-dicarboxylate

C18H24O12 (432.1268)


   

methyl 3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-3-phenylpropanoate

methyl 3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-3-phenylpropanoate

C25H20O7 (432.1209)


   

4,7-dimethyl (1s,4as,7r,7as)-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl (1s,4as,7r,7as)-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)


   

octacyclo[15.13.1.1²²,²⁶.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²¹,³¹.0³⁰,³²]dotriaconta-1,3,5(14),6(11),9,12,15,17(31),18,20,22(32),23,25,27,29-pentadecaene-7,8-dione

octacyclo[15.13.1.1²²,²⁶.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²¹,³¹.0³⁰,³²]dotriaconta-1,3,5(14),6(11),9,12,15,17(31),18,20,22(32),23,25,27,29-pentadecaene-7,8-dione

C32H16O2 (432.115)


   

4,7-dimethyl 7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl 7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)


   

4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxybenzaldehyde

4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxybenzaldehyde

C18H24O12 (432.1268)


   

(4ar,7as)-5-(acetyloxy)-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(4ar,7as)-5-(acetyloxy)-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

(7r,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-(4-methoxyphenyl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1(10),2,8-triene-5,11-dione

(7r,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-(4-methoxyphenyl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1(10),2,8-triene-5,11-dione

C25H20O7 (432.1209)


   

(1s,4as,5r,7as)-5-(acetyloxy)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,5r,7as)-5-(acetyloxy)-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C18H24O12 (432.1268)


   

n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

C20H20N2O9 (432.1169)


   

4,7-dimethyl (1r,4ar,7r)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl (1r,4ar,7r)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)


   

3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

3-hydroxy-3-methyl-5-oxo-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(2-methyl-4-oxopyran-3-yl)oxy]oxan-2-yl]methoxy}pentanoic acid

C18H24O12 (432.1268)


   

methyl (3r)-3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-3-phenylpropanoate

methyl (3r)-3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-3-phenylpropanoate

C25H20O7 (432.1209)


   

4,7-dimethyl (1s,4as,7s,7as)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

4,7-dimethyl (1s,4as,7s,7as)-5-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,6h,7h,7ah-cyclopenta[c]pyran-4,7-dicarboxylate

C18H24O12 (432.1268)